Clinical Trials · NCT07078838
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Enrollment
- 40
- Start date
- Aug 2026
- Locations
- 1 site, United States
- Primary endpoint
- Anti-proliferative effect of Tirzepatide